In addition, Cav-1 serum levels in controls and lung transplant recipients were measured to evaluate whether Cav-1 serum levels are influenced by genotype and can be useful as a biomarker to predict the development of BOS. The gene discussed is CAV1; the disease is Buschke-Ollendorff syndrome.